NPI: 1720056062 · HOLLYWOOD, FL 33021 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,676 | $3.05M |
| 2019 | 38,685 | $3.98M |
| 2020 | 38,026 | $4.31M |
| 2021 | 36,137 | $864K |
| 2022 | 16,475 | $931K |
| 2023 | 1,976 | $179K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 41,341 | 2,365 | $4.38M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 51,719 | 2,056 | $3.40M |
| J1270 | Injection, doxercalciferol, 1 mcg | 32,975 | 1,870 | $2.54M |
| A4657 | Syringe, with or without needle, each | 7,528 | 2,064 | $984K |
| J1756 | Injection, iron sucrose, 1 mg | 10,637 | 1,707 | $667K |
| 85041 | 2,429 | 1,456 | $213K | |
| 85048 | 2,376 | 1,427 | $212K | |
| 82728 | 2,118 | 1,277 | $197K | |
| 83540 | 2,169 | 1,300 | $195K | |
| 83550 | 2,136 | 1,285 | $195K | |
| 83970 | 1,862 | 838 | $192K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 374 | 168 | $61K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 557 | 237 | $31K |
| 82108 | 243 | 143 | $28K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 319 | 183 | $17K |
| 90662 | 76 | 46 | $6K | |
| 90674 | 47 | 32 | $3K | |
| G0008 | Administration of influenza virus vaccine | 69 | 45 | $3K |